Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty

被引：19
|
作者：
Carlsson, J
Miketic, S
Mueller, KH
Brom, J
Ross, R
vonEssen, R
Tebbe, U
机构：
[1] STIFTSKLIN AUGUSTINUM,MED KLIN B,MUNICH,GERMANY
[2] NOVARTIS PHARMA GMBH,NURNBERG,GERMANY
来源：
LANCET | 1997年 / 350卷 / 9086期
关键词：
D O I：
10.1016/S0140-6736(05)63456-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1225 / 1225
页数：1
相关论文
共 50 条
  • [1] Prior Cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty
    Carlsson, J
    Miketic, S
    Brom, J
    Ross, R
    Bachmann, H
    Tebbe, U
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 73 (02) : 165 - 171
  • [2] Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty
    Hayashida K.
    Tanaka M.
    Morita H.
    Hayashi F.
    Inada T.
    Suzuki H.
    Sakamoto T.
    Katsuragawa M.
    Hibino H.
    Kambara H.
    [J]. Heart and Vessels, 2002, 16 (4) : 137 - 145
  • [3] Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty
    Hayashida, K
    Tanaka, M
    Morita, H
    Hayashi, F
    Inada, T
    Suzuki, H
    Sakamoto, T
    Katsuragawa, M
    Hibino, H
    Kambara, H
    [J]. HEART AND VESSELS, 2002, 16 (04) : 137 - 145
  • [4] Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty
    Manegold, C
    Alwazzeh, M
    Jablonowski, H
    Adams, O
    Medve, M
    Seidlitz, B
    Heidland, U
    Häussinger, D
    Strauer, BE
    Heintzen, MP
    [J]. CIRCULATION, 1999, 99 (10) : 1290 - 1294
  • [5] Cytomegalovirus and restenosis after percutaneous transluminal coronary angioplasty
    Moreno, PR
    Palacios, IF
    [J]. CIRCULATION, 2000, 101 (14) : E163 - E163
  • [6] Elevated Chlamydia pneumoniae antibody and the risk of restenosis after percutaneous transluminal coronary angioplasty: Effect of clarithromycin in the prevention of restenosis
    Kumabashiri, I
    Horita, Y
    Uchiyama, K
    Hayashi, T
    Sakata, K
    Kazuyama, Y
    [J]. CIRCULATION, 1999, 100 (18) : 450 - 450
  • [7] Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary angioplasty: Results from the VERAS study
    Carlsson, J
    KarlHeinz, M
    Miketic, S
    Brom, J
    Ross, R
    vonEssen, R
    Tebbe, U
    [J]. CIRCULATION, 1997, 96 (08) : 3639 - 3639
  • [8] RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    PEDERSEN, HK
    VATNE, K
    SIMONSEN, S
    [J]. ACTA RADIOLOGICA, 1992, 33 (02) : 149 - 151
  • [9] RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    FOLEY, DP
    HERMANS, WM
    RENSING, BJ
    DEFEYTER, PJ
    SERRUYS, PW
    [J]. HERZ, 1992, 17 (01) : 1 - 17
  • [10] LIPOPROTEIN(A) IS NOT A RISK FACTOR FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    SCHUMACHER, M
    TIRAN, A
    EBER, B
    TOPLAK, H
    WILDERSTRUSCHNIG, M
    KLEIN, W
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (05): : 572 - 572
12345